Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: A series of four autopsies

Modern Pathology

Volumn 17, Issue 2, 2004, Pages 241-247

  Moore Maxwell, Crystal A ^a   Datto, Michael B ^a   Hulette, Christine M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autopsy; Chemotherapy; Neuropathology; Toxic leukoencephalopathy; White matter

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BRAIN TISSUE; BREAST CARCINOMA; CANCER STAGING; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHEMOTHERAPY; DISEASE COURSE; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; LEUKOENCEPHALOPATHY; LYMPHOMA; MALE; METASTASIS; MULTIPLE MYELOMA; NEUROPATHOLOGY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SPINAL CORD; VISUAL ACUITY; VISUAL FIELD DEFECT; WHITE MATTER; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTIINFARCT DEMENTIA; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 4644356753     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800049     Document Type: Article

References (34)

1. Filley CM. Toxic leukoencephalopathy. Clin Neuropharmacol 1999;22:249-260.
2. Rubin P, Hulette C, Khawly JMI, et al. Ocular toxicity following high dose chemotherapy and autologous bone marrow transplantation: case report and pathological correlation. Bone Marrow Transplant 1996;18:253-256.
3. Burger PC, Kamenar E, Schold C, et al. Encephalomyelopathy following high-dose BCNU therapy. Cancer 1981;48:1318-1327.
4. Filley C, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001;345:425-432.
5. Filley C, Kleinschmidt-DeMasters BK. Neurobehavioral aspects of cerebral white matter disorders. In: Fogel BS, Schiffer RB, Rao SM (eds). Neuropsychiatry. Williams & Wilkins: Baltimore, 1996, pp. 913-933.
6. Filley CM. The behavioral neurology of cerebral white matter. Neurology 1998;50:1535-1540.
7. Filley CM. Neurobehavioral anatomy. University Press of Colorado: Niwot, 1995.
8. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
9. Brashir R, Hochberg FH, Linggood RM, et al. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 1988;68:917-919.
10. Lebrun C, Chanalet S, Frenay M, et al. Leukoencephalopathy in multiple myeloma: 2 case reports. Ann Oncol 1999;10:1515-1517.
11. Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712-1722.
12. Asato R, Akiyama Y, Ito M, et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992;70:1997-2004.
13. Mulhern RK, Reddick WE, Palmer SL, et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46:834-841.
14. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-1228.
15. Crossen JR, Garwood D, Glatstein E, et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-642.
16. Rosenberg NL. Neurotoxicity of organic solvents. In: Rosenberg NL (ed). Occupational and Environmental Neurology. Butterworth-Heinemann: Boston, 1995, pp 71-113.
17. MMWR Organic solvents in the workplace. Morb Mortal Wkly Rep 1987;36:282-283.
18. Arlien-Soborg P, Bruhm P, Gyldensted C, Melgaard B. Chronic painters' syndrome: chronic toxic encephalopathy in house painters. Acta Neurol Scand 1979;60:149-156.
19. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents: a critical review. J Occup Med 1994;36:1079-1092.
20. Lees-Haley PR, Williams CW. Neurotoxicity of chronic low-dose exposure to organic solvents: a skeptical review. J Clin Psychol 1997;53:699-712.
21. Gamble JF. Low-level hydrocarbon solvent exposure and neurobehavioural effects. Occup Med (Lond) 2000;50:81-102.
22. Thuomas K-A, Moller C, Odkvist LM, et al. MR imaging in solvent-induced chronic toxic encephalopathy. Acta Radiol 1996;37:177-179.
23. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986;36:698-702.
24. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23:611-614.
25. Kornfeld M, Moser AB, Moser HW, et al. Solvent vapor abuse leukoencephalopathy: comparison to adrenoleukodystrophy. J Neuropathol Exp Neurol 1994;53:389-398.
26. Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990;40:532-534.
27. Bartzokis G, Goldstein IB, Hance DB, et al. The incidence of T2-weightedMR imaging Misc: signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific. AJNR Am J Neuroradiol 1999;20:1628-1635.
28. Bertram M, Egelhoff T, Schwarz S, et al. Toxic leukoencephalopathy following 'ecstasy' ingestion. J Neurol 1999;246:617-618.
29. Ricaurte GA, Forno LS, Wilson MA, et al. (+/-) 3,4- Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 1988;260:51-55.
30. Sprague JE, Everman SL, Nichols DE. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 1998;19:427-441.
31. Ginsberg MD, Hedley-Whyte ET, Richardson Jr EP. Hypoxic-ischemic leukoencephalopathy in man. Arch Neurol 1976;33:5-14.
32. Spengos K, Schwartz A, Hennerici M. Multifocal cerebral demyelination after magic mushroom abuse. J Neurol 2000;247:224-225.
33. Ghatak NR, Leshner RT, Price AC, et al. Remyelination in the human central nervous system. J Neuropathol Exp Neurol 1989;48:507-518.
34. Brustle O, Jones KN, Learish RD, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999;285:754-756.